* Newstin.co.uk is for sale! * After achieving our strategic milestone, we are offering for sale: Newstin.co.uk and all 14 related domains featuring 1 million unique visitors per month + continuously updated news database of 37 million articles in 12 world languages from 166,000 global and weighted sources + 2.1 billion metadata * To seize this unique chance, contact invest@newstin.com. * Newstin.co.uk is for sale! *

Scientific Discoveries

First Heart Failure Patients Successfully Implanted with Angioblast Systems´ "Off-the-Shelf" Adult..

Angioblast Systems Inc. today announced successful initial safety results following commencement of the world’s first clinical trial to use allogeneic adult stem cells obtained from an unrelated, universal donor to treat...

Merck Suspends Enrollment in Phase 2b Clinical Trial for I-vation TA

Focal/Grid Photocoagulation More Effective Treatment than IVTA for DME ?Over a 2-year period, focal/grid photocoagulation proved more effective and had fewer side effects than 1-mg or 4-mg doses of preservative-free...

Pain In Chronic Headache Alleviated By Nerve Stimulation Therapy

A novel therapy using a miniature nerve stimulator instead of medication for the treatment of profoundly disabling headache disorders improved the experience of pain by 80-95 percent, according to a new study from the...

Mediterranean diet 'halves' risk of skin cancer

Eating a Mediterranean diet can halve the risk of the most dangerous form of skin cancer, according to new research. Recent studies have shown Mediterranean foods can protect against other forms of cancer, as well as heart...

BMS Seeks to Become ??Next-Generation Pharma?

Top Searches Bio-IT World CHI's Network To have your event featured here, contact BMS Seeks to Become ‘Next-Generation Pharma’ Bristol sees the future of biotech and pharma one pearl at a time. By Allison Proffitt Oct. 8, 2008...

U.S. controls bird flu vaccines over bioweapon fears

When Indonesia's health minister stopped sending bird flu viruses to a laboratory in the U.S. for fear Washington could use them to make biological weapons, Defense Secretary Robert Gates called it "the nuttiest thing" he'd...

AIDS vaccine focus shifts after disappointments

WASHINGTON (Reuters) - A global AIDS vaccine conference this week will seek fresh strategies against the HIV virus, with experts weighing the value of basic laboratory research against large-scale human clinical trials after a...

On the trail of a targeted therapy for blood cancers

INDIANAPOLIS: Investigators from the Herman B Wells Center for Pediatric Research at the Indiana University School of Medicine are focusing on a family of blood proteins that they hope holds a key to decreasing the toxic...

Body's anti-HIV drug explained

Medicine & Health / HIV & AIDS Humans have a built-in weapon against HIV, but until recently no one knew how to unlock its potential. A study published online by the journal Nature reveals the atomic structure of this weapon –...

TAXUS(R) Express(R) Stent Shows Similarly Low Re-Intervention Rates in Patients With Diabetes...

NATICK, Mass. and WASHINGTON, Oct. 12 /PRNewswire-FirstCall/ -- Boston Scientific Corporation today announced results from an analysis of nearly 7,500 patients from its TAXUS ARRIVE 1 and 2 registries, which are designed to...

1 2 3 4 5 next »